Madrigal Pharmaceuticals, Inc. (MDGL)
511.84
-4.90
(-0.95%)
USD |
NASDAQ |
Aug 24, 16:00
511.84
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals Market Cap : 11.82B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 11.93B |
| August 20, 2026 | 11.99B |
| August 19, 2026 | 12.47B |
| August 18, 2026 | 12.11B |
| August 17, 2026 | 12.12B |
| August 14, 2026 | 11.72B |
| August 13, 2026 | 11.72B |
| August 12, 2026 | 12.38B |
| August 11, 2026 | 12.36B |
| August 10, 2026 | 11.90B |
| August 07, 2026 | 11.78B |
| August 06, 2026 | 11.79B |
| August 05, 2026 | 11.87B |
| August 04, 2026 | 11.72B |
| August 03, 2026 | 11.13B |
| July 31, 2026 | 10.79B |
| July 30, 2026 | 11.39B |
| July 29, 2026 | 12.63B |
| July 28, 2026 | 12.44B |
| July 27, 2026 | 12.73B |
| July 24, 2026 | 12.55B |
| July 23, 2026 | 12.52B |
| July 22, 2026 | 12.39B |
| July 21, 2026 | 12.60B |
| July 20, 2026 | 12.34B |
| Date | Value |
|---|---|
| July 17, 2026 | 12.75B |
| July 16, 2026 | 12.57B |
| July 15, 2026 | 12.68B |
| July 14, 2026 | 12.37B |
| July 13, 2026 | 12.24B |
| July 10, 2026 | 12.37B |
| July 09, 2026 | 12.90B |
| July 08, 2026 | 13.03B |
| July 07, 2026 | 12.57B |
| July 06, 2026 | 12.20B |
| July 02, 2026 | 12.17B |
| July 01, 2026 | 11.85B |
| June 30, 2026 | 12.37B |
| June 29, 2026 | 12.15B |
| June 26, 2026 | 11.81B |
| June 25, 2026 | 11.84B |
| June 24, 2026 | 11.75B |
| June 23, 2026 | 11.83B |
| June 22, 2026 | 11.82B |
| June 18, 2026 | 11.65B |
| June 17, 2026 | 11.52B |
| June 16, 2026 | 11.55B |
| June 15, 2026 | 11.52B |
| June 12, 2026 | 11.08B |
| June 11, 2026 | 10.93B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 27.07B |
| PTC Therapeutics, Inc. | 5.918B |
| Protagonist Therapeutics, Inc. | 10.00B |
| Exelixis, Inc. | 13.58B |
| Karyopharm Therapeutics, Inc. | 42.41M |
Market Cap Related Metrics
| PS Ratio | 10.31 |
| PEG Ratio | -139.45 |
| Price to Book Value | 22.57 |
| Price | 511.84 |
| Earnings Yield | -2.52% |
| PEGY Ratio | -139.45 |